These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 232620)
1. Modulation of the tumoricidal function of activated macrophages by bacterial endotoxin and mammalian macrophage activation factor (s). Hibbs JB; Weinberg JB; Chapman HA Adv Exp Med Biol; 1979; 121B():433-53. PubMed ID: 232620 [No Abstract] [Full Text] [Related]
2. Macrophage activation for tumor cytotoxicity: tumoricidal activity by macrophages from C3H/HeJ mice requires at least two activation stimuli. Ruco LP; Meltzer MS Cell Immunol; 1978 Nov; 41(1):35-51. PubMed ID: 363288 [No Abstract] [Full Text] [Related]
3. Macrophage activation for tumor cytotoxicity: genetic variation in macrophage tumoricidal capacity among mouse strains. Boraschi D; Meltzer MS Cell Immunol; 1979 Jun; 45(1):188-94. PubMed ID: 378423 [No Abstract] [Full Text] [Related]
4. Defective tumoricidal capacity of macrophages from A/J mice. II. Comparison of the macrophage cytotoxic defect of A/J mice with that of lipid A-unresponsive C3H/HeJ mice. Boraschi D; Meltzer MS J Immunol; 1979 Apr; 122(4):1592-97. PubMed ID: 376721 [No Abstract] [Full Text] [Related]
5. The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators. Fogler WE; Talmadge JE; Fidler IJ J Reticuloendothel Soc; 1983 Mar; 33(3):165-74. PubMed ID: 6834360 [TBL] [Abstract][Full Text] [Related]
6. Macrophage activation for tumor cytotoxicity: mechanisms of macrophage activation by lymphokines. Meltzer MS; Ruco LP; Leonard EJ Adv Exp Med Biol; 1979; 121B():381-98. PubMed ID: 397754 [No Abstract] [Full Text] [Related]
7. In vitro modulation of macrophage tumoricidal activity: partial characterization of a macrophage-activating factor(s) in supernatants of NaIO4-treated peritoneal cells. Weinberg JB; Hibbs JB J Reticuloendothel Soc; 1979 Sep; 26(3):283-93. PubMed ID: 228037 [No Abstract] [Full Text] [Related]
8. Role of macrophage lipids in regulating tumoricidal activity. II. Internal genetic and external physiologic regulatory factors controlling macrophage tumor cytotoxicity also control characteristic lipid changes associated with tumoricidal cells. Schlager SI; Meltzer MS Cell Immunol; 1983 Aug; 80(1):10-9. PubMed ID: 6872005 [TBL] [Abstract][Full Text] [Related]
9. Defective tumoricidal capacity of macrophages from P/J mice: tumoricidal defect involves abnormalities in lymphokine-derived activation stimuli and in mononuclear phagocyte responsiveness. Boraschi D; Meltzer MS J Immunol; 1980 Aug; 125(2):777-82. PubMed ID: 6993563 [No Abstract] [Full Text] [Related]
10. Endotoxin requirement for macrophage activation by lymphokines in a rapid microcytotoxicity assay. Taramelli D; Holden HT; Varesio L J Immunol Methods; 1980; 37(3-4):225-32. PubMed ID: 7005345 [TBL] [Abstract][Full Text] [Related]
11. Macrophage function in tumor-bearing mice: tumoricidal and chemotactic responses of macrophages activated by infection with Mycobacterium bovis, strain BCG. Meltzer MS; Stevenson MM J Immunol; 1977 Jun; 118(6):2176-81. PubMed ID: 325142 [No Abstract] [Full Text] [Related]
13. Defective tumoricidal capacity of macrophages from A/J mice. I. Characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli. Boraschi D; Meltzer MS J Immunol; 1979 Apr; 122(4):1587-91. PubMed ID: 376720 [TBL] [Abstract][Full Text] [Related]
14. Characterization of genetic defects in macrophage tumoricidal capacity: identification of murine strains with abnormalities in secretion of cytolytic factors and ability to bind neoplastic targets. Adams DO; Marino PA; Meltzer MS J Immunol; 1981 May; 126(5):1843-7. PubMed ID: 6783698 [TBL] [Abstract][Full Text] [Related]
15. Defective tumoricidal capacity of macrophages from P/J mice: characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli. Boraschi D; Meltzer MS J Immunol; 1980 Aug; 125(2):771-6. PubMed ID: 6993562 [TBL] [Abstract][Full Text] [Related]
16. Defective tumoricidal capacity of macrophages from A/J mice. III. Genetic analysis of the macrophage defect. Boraschi D; Meltzer MS J Immunol; 1980 Mar; 124(3):1050-3. PubMed ID: 6987306 [No Abstract] [Full Text] [Related]
17. Macrophage stimulation by bacterial lipopolysaccharides. III. Selective unresponsiveness of C3H/HeJ macrophages to the lipid A differentiation signal. Doe WF; Henson PM J Immunol; 1979 Nov; 123(5):2304-10. PubMed ID: 385780 [TBL] [Abstract][Full Text] [Related]
18. Interferon-induced enhancement of macrophage-mediated tumor cytolysis and its difference from activation by lymphokines. Boraschi D; Tagliabue A Eur J Immunol; 1981 Feb; 11(2):110-4. PubMed ID: 6163639 [TBL] [Abstract][Full Text] [Related]
19. Genetic aspects of macrophage activation for tumor cytotoxicity. Boraschi D Adv Exp Med Biol; 1982; 141():119-28. PubMed ID: 7046393 [No Abstract] [Full Text] [Related]
20. The effects of lipopolysaccharide, BCG-immune T lymphocytes, and lymphokines on generations of tumoricidal pulmonary macrophages in Syrian hamster. Panke ES; Zwilling BS; Somers SD; Campolito LB; Packer BJ Exp Lung Res; 1982 Feb; 3(1):81-90. PubMed ID: 7037379 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]